Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Nephro Care India Ltd

NSE: NEPHROCARE · Healthcare · 13 announcements

Share price
₹86.95
Market cap
₹143.3 Cr
Revenue (annual)
₹88.73 Cr
Net profit (annual)
₹3.37 Cr
P/E (TTM)
42.5×Sector 53.1×
Promoter holding
61.71%+0.00% QoQ
FII holding
0.96%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

11:57 IST NSE
Adverse Business Impact

Nephro Care India Adverse Business Impact

Nephro Care India closes its Salt Lake, Kolkata dialysis unit from September 15, 2026 due to licensing constraints. Operations cease and premises will be vacated.

16:03 IST NSE
Annual General Meeting

Nephro Care India Annual General Meeting

Nephro Care India Limited submitted its Annual Report for FY 2025-26 and the Notice for its 12th Annual General Meeting scheduled for September 25, 2026.

17:22 IST NSE
Other Announcement

Nephro Care India Other Announcement

Nephro Care India Limited submitted its Statement of Deviation or Variation regarding IPO issue proceeds for the quarter ending June 30, 2026, confirming no deviations.

12:17 IST NSE
Legal & Regulatory

Nephro Care India Legal & Regulatory

Nephro Care India Limited informs that SEBI corporate governance regulations do not apply to it for Q June 2026. The filing records this compliance exemption.

15:04 IST NSE
Results Correction

Nephro Care India Results Correction

Nephro Care submitted revised half‑yearly audited financial results, reporting total income of ₹2,674.63 crore. The filing addresses the exchange’s clarification request.

Value
₹2,675 Cr